Meeting
2019 Genitourinary Cancers Symposium
Prophylactic cranial irradiation (PCI) significantly decreases risk of brain metastases in patients with bulky, higher stage small-cell urothelial cancer.
Authors
Seungtaek Choi
The University of Texas M. D. Anderson Cancer Center, Houston, TX
Seungtaek Choi , Matthew T Campbell , Amishi Yogesh Shah , Neema Navai , Ashish M. Kamat , Colin P.N. Dinney , Quynh Nguyen , Arlene O. Siefker-Radtke
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, Testicular, and Adrenal Cancers
Sub Track
Urothelial Carcinoma
Clinical Trial Registration Number
NCT00756639
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 486)
DOI
10.1200/JCO.2019.37.7_suppl.486
Abstract #
486
Poster Bd #
L13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Factors associated with improved outcomes in surgically resectable small cell urothelial cancer (SCUC).
First Author: Omar Alhalabi
Poster
2021 ASCO Annual Meeting
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts).
First Author: Carlo Resteghini
Poster
2024 ASCO Annual Meeting
Harmonizing cancer care delivery for AYAs with osteosarcoma: Comparison of pediatric and medical oncology approaches in a single center.
First Author: Ariel Nash
Poster
2023 ASCO Annual Meeting
Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate as neoadjuvant therapy for osteosarcoma: A single-arm, exploratory phase II trial.
First Author: Qinglian Tang